NKp30, NKp44, and NKp46 are all type I immunoglobulin (Ig) transmembrane receptors where NKp30 and NKp44 can also be expressed on T-cells, primarily γδT-cells in different tumor models but at significantly lower levels [21,22]. This evidence concerns the gene NCR3 and neoplasm.